Sionna Therapeutics, INC. (SION) — 10-Q Filings
All 10-Q filings from Sionna Therapeutics, INC.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Sionna's Losses Mount Amid R&D Spend, Capital Infusion
— Nov 5, 2025 Risk: high
Sionna Therapeutics, Inc. (SION) reported a net loss of $54.8 million for the nine months ended September 30, 2025, an increase from $45.8 million for the same -
Sionna's Q2 Losses Widen to $45.3M Amid R&D Push
— Aug 11, 2025 Risk: high
Sionna Therapeutics, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage as a pharmaceutical com -
Sionna Therapeutics Files Q1 2025 10-Q
— May 12, 2025 Risk: low
Sionna Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 21 Hickory Drive, Suite 500, Waltham, MA, ope
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX